首站-论文投稿智能助手
典型文献
Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice
文献摘要:
Dear Editor, Hearing loss is the most common sensory disorder in the world.Among cases of non-syndromic hearing loss,which account for 70%of all cases of genetic hearing loss,around 80%of cases arise from autosomal recessive loss-of-function mutations that require repair,rather than disruption,of the mutant allele.1 CRISPR/Cas9-mediated homology-directed repair(HDR)-based therapies have the potential to cure many genetic diseases because this class of therapeutics can achieve arbitrary base changes as well as the insertion or deletion of DNA fragments.2 However,HDR is considered to be largely restricted to dividing cells and is generally inefficient in animal tissues in vivo.3 CRISPR/Cas9-mediated HDR has been successfully used to efficiently correct the Cdh23ahl allele in C57BL/6NTac zygotes and to rescue the associated auditory phenotype.4 However,there have been no reports of applying this strategy at the postnatal stage(i.e.,in vivo)to achieve hearing preservation in animal models of hereditary hearing loss.An efficient HDR strategy in nondividing mammalian cells(including cochlear hair cells)holds promise for developing treatments for recessive hearing loss.We previously devised a new homology-mediated end joining(HMEJ)-based strategy using CRISPR/Cas9-mediated cleavage of the transgene donor vector,which contains guide RNA target sites and~800 bp of homology arms,and cleavage of the targeted site in the genome5(Supplementary information,Fig.S1).This approach,which is an optimized version of HDR,achieved transgene integration in mouse and monkey embryos,as well as in hepatocytes and neurons in vivo,with an efficiency much greater than homologous recombination-and nonhomologous end joining-based strategies.
文献关键词:
作者姓名:
Xi Gu;Xinde Hu;Daqi Wang;Zhijiao Xu;Fang Wang;Di Li;Geng-lin Li;Hui Yang;Huawei Li;Erwei Zuo;Yilai Shu
作者机构:
ENT institute and Department of Otorhinolaryngology,Eye & ENT Hospital,State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science,Fudan University,Shanghai,China;Institutes of Biomedical Sciences,Fudan University,Shanghai,China;Department of Otolaryngology,the First Affiliated Hospital of Fujian Medical University,Fuzhou,China;NHC Key Laboratory of Hearing Medicine(Fudan University),Shanghai,China;Institute of Neuroscience,State Key Laboratory of Neuroscience,Key Laboratory of Primate Neurobiology,CAS Center for Excellence in Brain Science and Intelligence Technology,Shanghai Research Center for Brain Science and Brain-Inspired Intelligence,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,China;State Key Lab for Conservation and Utilization of Subtropical Agric-Biological Resources,Guangxi University,Nanning,China;Shenzhen Branch,Guangdong Laboratory for Lingnan Modern Agriculture,Genome Analysis Laboratory of the Ministry of Agriculture,Agricultural Genomics Institute at Shenzhen,Chinese Academy of Agricultural Sciences,Shenzhen,China;The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science,Fudan University,Shanghai,China
引用格式:
[1]Xi Gu;Xinde Hu;Daqi Wang;Zhijiao Xu;Fang Wang;Di Li;Geng-lin Li;Hui Yang;Huawei Li;Erwei Zuo;Yilai Shu-.Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice)[J].细胞研究(英文版),2022(07):699-702
A类:
Hearing,Cdh23ahl,6NTac,nondividing,HMEJ,genome5,nonhomologous
B类:
Treatment,autosomal,recessive,hearing,loss,via,vivo,CRISPR,Cas9,mediated,optimized,homology,directed,repair,mice,Dear,Editor,most,common,sensory,disorder,world,Among,cases,syndromic,which,account,genetic,around,arise,from,function,mutations,that,require,rather,than,disruption,mutant,allele,HDR,therapies,have,potential,cure,many,diseases,because,this,class,therapeutics,can,arbitrary,changes,well,insertion,deletion,fragments,However,considered,largely,restricted,cells,generally,inefficient,animal,tissues,has,been,successfully,used,efficiently,correct,C57BL,zygotes,rescue,associated,auditory,phenotype,there,reports,applying,strategy,postnatal,stage,preservation,models,hereditary,An,mammalian,including,cochlear,hair,holds,promise,developing,treatments,We,previously,devised,new,end,joining,using,cleavage,transgene,donor,vector,contains,guide,sites,bp,arms,targeted,Supplementary,information,Fig,S1,This,approach,version,achieved,integration,mouse,monkey,embryos,hepatocytes,neurons,efficiency,much,greater,recombination,strategies
AB值:
0.536288
相似文献
RIOX1-demethylated cGAS regulates ionizing radiation-elicited DNA repair
Yanxuan Xiao;Jingyi Li;Xiaoyu Liao;Yumin He;Tao He;Cuiping Yang;Lu Jiang;So Mi Jeon;Jong-Ho Lee;Yongbin Chen;Rui Liu;Qianming Chen-State Key Laboratory of Oral Diseases,National Clinical Research Center for Oral Diseases,Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management,West China Hospital of Stomatology,Sichuan University,Chengdu,Sichuan 610041,China;The Second Affiliated Hospital of Chengdu Medical College,China National Nuclear Corporation 416 Hospital,Chengdu,Sichuan 610051,China;School of Biological Sciences and Technology,Chengdu Medical College,Chengdu 610599,China;Department of Cardio-thoracic Surgery,the Second Affiliated Hospital of Chengdu Medical College,China National Nuclear Corporation 416 Hospital,Chengdu,Sichuan 610051,China;Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences Yunnan Province,Kunming Institute of Zoology,Kunming,Yunnan 650223,China;Department of Health Sciences,The Graduate School of Dong-A University,Busan 49315,Republic of Korea;Department of Biological Sciences,Dong-A University,Busan 49315,Republic of Korea;Center for Excellence in Animal Evolution and Genetics,Chinese Academy of Sciences,Kunming,Yunnan 650223,China
Restoration of FMRP expression in adult V1 neurons rescues visual deficits in a mouse model of fragile X syndrome
Chaojuan Yang;Yonglu Tian;Feng Su;Yangzhen Wang;Mengna Liu;Hongyi Wang;Yaxuan Cui;Peijiang Yuan;Xiangning Li;Anan Li;Hui Gong;Qingming Luo;Desheng Zhu;Peng Cao;Yunbo Liu;Xunli Wang;Min-hua Luo;Fuqiang Xu;Wei Xiong;Liecheng Wang;Xiang-yao Li;Chen Zhang-State Key Laboratory of Membrane Biology,PKU-IDG/McGovem Institute for Brain Research,School of Life Sciences,Peking University,Beijing 100871,China;School of Basic Medical Sciences,Beijing Key Laboratory of Neural Regeneration and Repair,Capital Medical University,Beijing 100069,China;Peking-Tsinghua Center for Life Sciences,Academy for Advanced Interdisciplinary Studies,Peking University,Beijing 100871,China;School of Mechanical Engineering and Automation,Beihang University,Beijing 100191,China;School of Life Sciences,Tsinghua University,Beijing 100084,China;Britton Chance Center for Biomedical Photonics,Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology,Wuhan 430074,China;State Key Laboratory of Brain and Cognitive Sciences,Institute of Biophysics,Chinese Academy of Sciences(CAS),Beijing 100101,China;Institute of Laboratory Animal Science,Peking Union Medical College/Chinese Academy of Medical Science,Beijing 100021,China;Laboratory Animal Center,Fujian University of Tradition Chinese Medicine,Fuzhou 350122,China;State Key Laboratory of Virology,CAS Center for Excellence in Brain Science and,Intelligence Technology,Wuhan Institute of Virology,CAS,Wuhan 430071,China;Center for Brain Science,Key Laboratory of Magnetic Resonance in Biological Systems and State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics,Wuhan Institute of Physics and Mathematics,CAS,Center for Excellence in Brain Science and Intelligence Technology,Chinese Academy of Sciences,Wuhan 430071,China;Department of Physiology,Anhui Medical University,Hefei 230032,China;Department of Physiology,Institute of Neuroscience and Collaborative Innovation Center for Brain Science,School of Medicine,Zhejiang University,Hangzhou 310058,China
Long-term correction of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration
Xi Chen;Xuran Niu;Yang Liu;Rui Zheng;Lei Yang;Jian Lu;Shuming Yin;Yu Wei;Jiahao Pan;Ahmed Sayed;Xueyun Ma;Meizhen Liu;Fengxiang Jing;Mingyao Liu;Jiazhi Hu;Liren Wang;Dali Li-Shanghai Frontiers Science Center of Genome Editing and Cell Therapy,Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;The MOE Key Laboratory of Cell Proliferation and Differentiation,Genome Editing Research Center,School of Life Sciences,Peking-Tsinghua Center for Life Sciences,Peking University,Beijing 100871,China;Xinhua Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China;Biochemistry Laboratory,Chemistry Department,Faculty of Science,Assiut University,Assiut 71516,Egypt;Shanghai Turtle Technology Co.,Shanghai 201900,China
CRISPR/Cas9-mediated genome editing reveals 12 testis-enriched genes dispensable for male fertility in mice
Yuki Oyama;Haruhiko Miyata;Keisuke Shimada;Yoshitaka Fujihara;Keizo Tokuhiro;Thomas X Garcia;Martin M Matzuk;Masahito Ikawa-Graduate School of Pharmaceutical Sciences,Osaka University,Suita,Osaka 565-0871,Japan;Department of Experimental Genome Research,Research Institute for Microbial Diseases,Osaka University,Suita,Osaka 565-0871,Japan;Department of Bioscience and Genetics,National Cerebral and Cardiovascular Center,Suita,Osaka 564-8565,Japan;Department of Genome Editing,Institute of Biomedical Science,Kansai Medical University,Hirakata,Osaka 573-1191,Japan;Center for Drug Discovery,Baylor College of Medicine,Houston,TX 77030,USA;Department of Pathology and Immunology,Baylor College of Medicine,Houston,TX 77030,USA;Department of Biology and Biotechnology,University of Houston-Clear Lake,Houston,TX 77058,USA;The Institute of Medical Science,The University of Tokyo,Minato-ku,Tokyo 108-8639,Japan
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。